Finally, among 67 genes in 17q23, high PRR11 mRNA levels also correlated with a shorter RFS in patients with ER+/HER2− breast cancer treated with endocrine therapy in the Kaplan–Meier Plotter database (Supplementary Fig. 2f). The gene discussed is PRR11; the disease is breast carcinoma.